News
- BusinessReuters
Bombardier reveals NetJets as the buyer of 12 Challenger business jets
At list prices, the order was valued at $326.4 million at the time of signing, but could amount to more than $6 billion if NetJets exercises its option for all 232 jets. Ahead of its investor day on Wednesday, Bombardier said it was on track to hit its 2025 goals, which include revenue rising to over $9 billion.
1 min read - BusinessGuruFocus.com
East West Bancorp Inc's Dividend Analysis
East West Bancorp Inc (NASDAQ:EWBC) recently announced a dividend of $0.55 per share, payable on 2024-05-17, with the ex-dividend date set for 2024-05-02. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into East West Bancorp Inc's dividend performance and assess its sustainability.
4 min read - BusinessGuruFocus.com
Lamb Weston Holdings Inc's Dividend Analysis
Lamb Weston Holdings Inc (NYSE:LW) recently announced a dividend of $0.36 per share, payable on 2024-05-31, with the ex-dividend date set for 2024-05-02. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Lamb Weston Holdings Inc's dividend performance and assess its sustainability.
4 min read - BusinessGuruFocus.com
Commerzbank AG's Dividend Analysis
Commerzbank AG (CRZBY) recently announced a dividend of $0.38 per share, payable on 2024-05-16, with the ex-dividend date set for 2024-05-02. Using the data from GuruFocus, let's look into Commerzbank AG's dividend performance and assess its sustainability. What Does Commerzbank AG Do?
3 min read - BusinessReuters
Amgen investors await weight-loss drug data
Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-loss drug candidates when it reports quarterly earnings on Thursday. Amgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting and analyzing the data," Amgen Chief Scientific Officer Jay Bradner told Reuters i
3 min read - BusinessGuruFocus.com
Hapag-Lloyd AG's Dividend Analysis
Hapag-Lloyd AG (HPGLY) recently announced a dividend of $4.96 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-05-02. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Hapag-Lloyd AG's dividend performance and assess its sustainability.
4 min read
